MD vs SGRY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

MD

51.8
AI Score
VS
SGRY Wins

SGRY

59.5
AI Score

Investment Advisor Scores

MD

52score
Recommendation
HOLD

SGRY

60score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MD SGRY Winner
Net Income 9.45M 69.42M MD
Operating Income 196.48M 98.58M SGRY
ROE 97.7% 7.9% SGRY
ROA 0.4% 3.3% MD
Total Assets 2.30B 2.13B SGRY
Cash 69.70M 288.88M MD
Debt/Equity 152.37 0.69 MD
Current Ratio 1.94 1.32 SGRY

Relative Price Performance (Last 90 Days)

MD 1M: +1.0% · 3M: +10.8% SGRY 1M: -6.1% · 3M: -3.7%

Current Technical Phase

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.4% over 20 days), RSI 53

RSI (14): 53.2 · Price: $26.77

SGRY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.2 · Price: $14.38

Fundamentals Snapshot

Metric MD SGRY
Market Cap
Forward P/E 11.0 22.9
Trailing P/E 12.8
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.2%
Operating Margin 0.1% 0.1%
EPS 2.09 -0.69
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SGRY is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.